Evidence map›Paper›PMID 35995048›Full record

ReviewAnnual review of nutrition2022

Obesity Dysregulates the Immune Response to Influenza Infection and Vaccination Through Metabolic and Inflammatory Mechanisms.

Saame Raza Shaikh, Nancie J MacIver, Melinda A Beck

Abstract readReview
In one paragraph

Review in Annual review of nutrition, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Observational
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Saame Raza ShaikhDepartment of Nutrition, Gillings School of Global Public Health and School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; email: shaikhsa@email.unc.edu, nancie_maciver@med.unc.edu, melinda_beck@med.unc.edu.
Nancie J MacIverDepartment of Nutrition, Gillings School of Global Public Health and School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; email: shaikhsa@email.unc.edu, nancie_maciver@med.unc.edu, melinda_beck@med.unc.edu.
Melinda A BeckDepartment of Nutrition, Gillings School of Global Public Health and School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; email: shaikhsa@email.unc.edu, nancie_maciver@med.unc.edu, melinda_beck@med.unc.edu.

Funding

UNIV OF NORTH CAROLINA CLINICAL NUTRITION RESEARCH UNITP30DK056350 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SUSAN M. SMITH · 1999 to 2026
$31.6M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007171 · NIGMS · DUKE UNIVERSITY · PI KONTOS, CHRISTOPHER D · 1985 to 2021
$31.2M
Vanderbilt Clinical Oncology Research Career Development ProgramK12CA090625 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Debra L. Friedman, Paula Jill Hurley · 2001 to 2026
$16.9M
Mechanisms of T cell inflammation in obesity-induced type 2 diabetesR01DK106090 · NIDDK · DUKE UNIVERSITY · PI MACIVER, NANCIE · 2015 to 2019
$1.8M
Viral Adaptation to Host Selenium StatusR01AI082298 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BECK, MELINDA A. · 2010 to 2012
$1.1M
Leptin as a Regulator of T Cell Metabolism and FunctionK08DK087944 · NIDDK · DUKE UNIVERSITY · PI MACIVER, NANCIE · 2010 to 2014
$678k
Metabolic reprogramming to improve EGFRvIII CAR T cell persistenceR21CA253163 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MACIVER, NANCIE · 2021 to 2022
$402k
SPMs, linoleic acid, and antibody levels in obesityR03AI159308 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SHAIKH, SAAME R · 2021 to 2022
$149k
NCI NIH HHS K12 CA090625NCI NIH HHS R21 CA253163NIAID NIH HHS R01 AI082298NIAID NIH HHS R03 AI159308NIDDK NIH HHS K08 DK087944NIDDK NIH HHS P30 DK056350NIDDK NIH HHS R01 DK106090NIGMS NIH HHS T32 GM007171
6 · The paper itself

Abstract

The COVID-19 pandemic demonstrates that obesity alone, independent of comorbidities, is a significant risk factor for severe outcomes from infection. This susceptibility mirrors a similar pattern with influenza infection; that is, obesity is a unique risk factor for increased morbidity and mortality. Therefore, it is critical to understand how obesity contributes to a reduced ability to respond to respiratory viral infections. Herein, we discuss human and animal studies with influenza infection and vaccination that show obesity impairs immunity. We cover several key mechanisms for the dysfunction. These mechanisms include systemic and cellular level changes that dysregulate immune cell metabolism and function in addition to how obesity promotes deficiencies in metabolites that control the resolution of inflammation and infection. Finally, we discuss major gaps in knowledge, particularly as they pertain to diet and mechanisms, which will drive future efforts to improve outcomes in response to respiratory viral infections in an increasingly obese population.

Indexed as

COVID-19Influenza, HumanAnimalsHumansImmunityObesityPandemicsVaccinationimmunityinfluenzametabolismobesityspecialized proresolving mediators

Identifiers

PMID35995048
PMCPMC10880552

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.